Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.

A total of 99 patients with head and neck cancer who were to undergo surgery were randomized in a prospective comparative study of sulbactam-ampicillin (1:2 ratio; four doses of 3 g of ampicillin and 1.5 g of sulbactam intravenously [i.v.] every 6 h) versus clindamycin (four doses of 600 mg i.v. eve...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Phan, M, Van der Auwera, P, Andry, G, Aoun, M, Chantrain, G, Deraemaecker, R, Dor, P, Daneau, D, Ewalenko, P, Meunier, F
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1992
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192428/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416895/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.9.2014
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!